P562 5-ASA in ulcerative colitis: Are they really needed in the biological therapy era?
ECCO'20 Vienna
2020
P563 Shared decision-making in pregnancy in inflammatory bowel disease: Design of a pregnancy in IBD decision aid (PIDA)
ECCO'20 Vienna
2020
P564 Psychological acceptance of surgery in patients with inflammatory bowel disease undergoing intestinal resection
ECCO'20 Vienna
2020
P568 An open-label, multicenter, phase ib, pharmacokinetic (pk) and safety study of a fimh blocker, Sibofimloc (TAK-018/EB8018), in patients with Crohn’s disease (CD)
ECCO'20 Vienna
2020
P569 The role of multidrug-resistant infections in IBD patients undergoing surgery
ECCO'20 Vienna
2020
P570 The burden of anaemia remains significant over time in patients with inflammatory bowel disease at a tertiary referral centre
ECCO'20 Vienna
2020
P571 Self-Medication with steroids in ulcerative colitis: Results of a patient survey
ECCO'20 Vienna
2020
P573 Frequency and effectiveness of empirical anti-TNF dose intensification in inflammatory bowel disease: an on-going systematic review with meta-analysis
ECCO'20 Vienna
2020
P575 Real-world effectiveness and safety of ustekinumab for the treatment of refractory Crohn’s disease: The Scottish ustekinumab cohort
ECCO'20 Vienna
2020
P576 The value of small bowel capsule endoscopy in the change of therapeutic management in patients with established Crohn’s disease
ECCO'20 Vienna
2020
P578 Inter-observer agreement of an expert panel for gastrointestinal ultrasound in ulcerative colitis
ECCO'20 Vienna
2020